Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Proof of Concept Study of Combined Topical Growth Factor and Protease Inhibitor in Chronic Wound Healing

Next Previous
X
Search
Trial Profile

Proof of Concept Study of Combined Topical Growth Factor and Protease Inhibitor in Chronic Wound Healing

Status: Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 03 Oct 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Becaplermin (Primary)
  • Indications Diabetic foot ulcer; Leg ulcer
  • Focus Proof of concept; Therapeutic Use

    • Most Recent Events

    • 09 Apr 2018 Planned initiation date changed from 1 Oct 2017 to 1 Aug 2018.
    • 28 Aug 2017 Planned End Date changed from 1 Sep 2019 to 1 Sep 2020.
    • 28 Aug 2017 Planned primary completion date changed from 1 Sep 2019 to 1 Sep 2020.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top